Immunomodulation in Pediatric Asthma

Area of Science:

• Pediatric Pulmonology
• Immunology
• Pharmacology

Background:

• Childhood asthma is a heterogeneous respiratory disease with diverse immune mechanisms.
• Current management focuses on symptom control and risk reduction using inhaled corticosteroids (ICS) and controllers.
• Standard therapies are not disease-modifying and are often ineffective for severe, uncontrolled pediatric asthma.

Purpose of the Study:

• To review current and emerging therapeutic strategies for pediatric asthma.
• To focus on immunomodulatory treatments, particularly biologic therapies.
• To update knowledge on targeting specific inflammatory pathways in pediatric asthma.

Main Methods:

• Literature review of current and novel asthma treatments.
• Focus on immunomodulatory and biologic therapies.
• Analysis of therapeutic options for pediatric asthma management.

Main Results:

• Standard therapies like ICS offer symptom control but do not modify disease progression.
• Severe pediatric asthma often remains uncontrolled with current treatments.
• Biologic therapies represent a promising avenue for targeted immunomodulation.

Conclusions:

• Novel biologic therapies show potential for modifying pediatric asthma.
• Targeting specific inflammatory pathways is crucial for severe cases.
• Further research into immunomodulatory treatments is warranted for better asthma control.